National Resilience Acquires SwiftScale Biologics

December 2, 2021

National Resilience, Inc. (Resilience) has acquired SwiftScale Biologics, a San Leandro, California–based developer of cell-free protein synthesis (CFPS) technology. Resilience said it will integrate SwiftScale’s CFPS capabilities into its biomanufacturing platforms to accelerate production of complex biologics and next-generation therapies.

Buyers
National Resilience, Inc. (Resilience)
Targets
SwiftScale Biologics
Industry
Biotechnology
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.